NDC 42291-301-30 - Gabapentin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 42291-301
- Requested NDC
- 42291-301-30
- Package NDCs from labels
- 42291-301-50, 42291-301-30
- Manufacturer
- AvKARE
- Effective date
- 2022-01-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Gabapentin - AvKARE | AvKARE | 2022-01-13 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-13 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 42291-301-10 | EA - Each | 42291-301 | 2148c67a-da4a-4fc6-9965-d2dc7283324f | 1 | 2013-02-13 |
| 42291-301-18 | EA - Each | 42291-301 | a94c3a5a-b7d2-4162-bcc7-69c42cf25512 | 1 | 2013-02-13 |
| 42291-301-27 | EA - Each | 42291-301 | a3157c8a-e4c6-4912-b9da-4665436ad940 | 1 | 2013-02-13 |
| 42291-301-30 | EA - Each | 42291-301 | 4b3388ae-99e2-4ac5-a747-7f90798c60a8 | 1 | 2013-02-13 |
| 42291-301-50 | EA - Each | 42291-301 | 5f4b3f45-a21d-4e20-a2e3-3296ff0a4325 | 1 | 2018-10-11 |
| 42291-301-90 | EA - Each | 42291-301 | 7169cf0d-6ae5-416d-81f2-8160bb398680 | 1 | 2013-02-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gabapentin | GABAPENTIN | St. Mary's Medical Park Pharmacy | f93eaa4f-cc1a-10ab-e053-6394a90a5ffc | 2026-06-02 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Direct_Rx | f8998c1c-c359-6f01-e053-6294a90aebf4 | 2026-06-01 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| gabapentin | GABAPENTIN | Proficient Rx LP | c7674ea5-276b-4bb3-821b-4ac05c9e64e6 | 2026-06-01 | Warnings, Adverse reactions | 310432 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Amneal Pharmaceuticals LLC | 507bf6d0-e7a2-413d-9848-cd2445a1411d | 2026-05-30 | Warnings, Adverse reactions | ANDA078428 310430 310432 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Laurus Labs Limited | 07aa1bcc-df05-44fa-92d4-63894e0e6cd6 | 2026-05-28 | Warnings, Adverse reactions | 310430 310432 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | 03031adf-d36b-45ec-944e-dfce5a5de91a | 2026-05-28 | Warnings, Adverse reactions | 310430 310432 310431 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Pangea Pharmaceuticals, LLC | 5eff7ad8-0d31-4372-82a2-ac9f549d8796 | 2026-05-22 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Bryant Ranch Prepack | 397fd6d3-317b-4b61-a52b-3a09ca1d88a4 | 2026-05-22 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Bryant Ranch Prepack | 13640281-26b4-402e-8f69-7c81cd6e0376 | 2026-05-22 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Amici Pharma, Inc. | 1ea83c18-7107-41f4-8305-62725c1c45c8 | 2026-05-19 | Warnings, Adverse reactions | 310430 310432 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Cardinal Health 107, LLC | d4f21e97-5e55-44c9-9b31-5f79ac2eb512 | 2026-05-18 | Warnings, Adverse reactions | 310430 310431 6CW7F3G59X |
| Neurontin | GABAPENTIN | Viatris Specialty LLC | 97935fd9-1d4a-43b6-a5d9-de994591187b | 2026-05-12 | Warnings, Adverse reactions | 310430 310432 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Cardinal Health 107, LLC | eeb19a5a-b31d-4df8-9546-0b2b5eb5db07 | 2026-05-07 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Major Pharmaceuticals | 152adf1d-ec0c-4561-bf80-e4c7da158723 | 2026-05-04 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Major Pharmaceuticals | 999f3685-2eac-467e-bed2-1d0c36aaf0ed | 2026-05-04 | Warnings, Adverse reactions | 310430 310432 310431 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Preferred Pharmaceuticals Inc. | 180b99a5-7d3d-4ee5-a0cc-1ae0ede646ee | 2026-05-04 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Preferred Pharmaceuticals Inc. | 35da078b-0da0-4757-a6c4-a9144c37e8e1 | 2026-05-01 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Preferred Pharmaceuticals Inc. | 38119f2e-33b3-4c3c-99b7-9335d8d280d4 | 2026-05-01 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | St. Mary's Medical Park Pharmacy | b8b7e045-a7fe-8539-e053-2a95a90a40f8 | 2026-05-01 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| Gabapentin | GABAPENTIN | St Mary's Medical Park Pharmacy | de990f96-96bc-406d-e053-2995a90abebb | 2026-05-01 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.